Home › Funds › Point72 Asset Management › ADPT
Point72 Asset Management position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
Latest position (Q1 2026)1.02M sh
Reported value held$14.18M
Portfolio Weight0.02%
First reportedQ3 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.71M | $31.14M | New |
| Q4 2023 | 3.72M | $18.24M | Reduce |
| Q1 2024 | 274.70K | $881.79K | Reduce |
| Q3 2024 | 495.49K | $2.54M | New |
| Q4 2024 | 937.33K | $5.62M | Add |
| Q2 2025 | 1.37M | $16.01M | New |
| Q3 2025 | 319.47K | $4.78M | Reduce |
| Q4 2025 | 203.07K | $3.30M | Reduce |
| Q1 2026 | 1.02M | $14.18M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- BlackRock Inc 15.14M sh · $324.73M · Q2 2026
- Vanguard Group 11.28M sh · $183.22M · Q4 2025
- Wellington Management Group 5.91M sh · $126.80M · Q2 2026
- D. E. Shaw & Co 4.63M sh · $99.22M · Q2 2026
- Geode Capital Management 3.64M sh · $78.13M · Q2 2026
- UBS Group AG 3.13M sh · $67.15M · Q2 2026
- Invesco Ltd 3.09M sh · $66.37M · Q2 2026
- Goldman Sachs Group 2.98M sh · $64.01M · Q2 2026
- Arrowstreet Capital 2.52M sh · $54.15M · Q2 2026
- ARK Invest 2.09M sh · $44.84M · Q2 2026
- Bank of America Corp 1.73M sh · $37.11M · Q2 2026